Skip to main content
. 2021 May 12;16:217. doi: 10.1186/s13023-021-01829-x

Table 1.

Summary of disease stages

Disease stage CLN2 clinical rating scale score (motor score + language score) Additional characteristics
6 6 (3 + 3) None
5 5 (2 + 3) None
4 4 (2 + 2) None
3 3 (1 + 2) None
2 2 (1 + 1) None
1 1 (1 + 0) None
0 0 None
0 + VL 0 With vision loss
0 + VL + PC 0 With vision loss and requiring palliative care

Disease progression increases with decreasing disease stage

CLN2, neuronal ceroid lipofuscinosis type 2; PC, palliative care; VL, vision loss